NCT00203476View on ClinicalTrials.gov

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

HyperlipidemiaHypercholesterolemia

Interventions

DRUG

Niacin

DRUG

Colestipol

DRUG

Ezetimibe

Trial Locations (1)

35404

Tuscaloosa Research & Education Advancement Corporation, Tuscaloosa

All Listed Sponsors

collaborator

American Society of Health-System Pharmacists Research and Education Foundation

OTHER

lead

Tuscaloosa Research & Education Advancement Corporation

OTHER

NCT00203476 - A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction | Biotech Hunter | Biotech Hunter